JPRN-UMIN000044415已完成Unknown
Evaluation of the improving effects on liver function, status of fatigue, mood, and sleep after ingestion of the supplement - Evaluation of the improving effects on liver function, status of fatigue, mood, and sleep after ingestion of the supplement
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 64years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Subjects who ALT levels >= 51 U / L or AST levels >= 51 U / L or gamma-GTP levels >= 101 U / L on the preliminary examination (2) Subjects who are positive for HCV antibody or HbsAg on the preliminary examination (3) Subjects who cannot accomplish the intact inspection procedure as prescribed (4) Subjects who are judged as unsuitable for the study based on the results of the lifestyle questionnaire (5) Subjects who constantly use health food richly containing involvement ingredient (6) Subjects who constantly use supplements or drugs affecting the liver function (7) Subjects who constantly use supplements or drugs affecting the status of fatigue, mood, and sleep (8) Subjects who have serious illnesses such as diabetes, liver disease, kidney disease, heart disease, and cancer or history of those illnesses (9) Subjects having possibilities for emerging allergy related to the study (10) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (11) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (12) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (13) Subjects who intend to become pregnant or lactating during the test period (14) Subjects who habitually do intense exercise such as marathon. (15) Subjects who take constant or frequent night shifts (16) Subjects judged as unsuitable for the study by the principle investigator for other reasons
研究者
相似试验
已完成
不适用
Examination of liver function improvement effect by administering a Ipragliflozin.DiabeticJPRN-UMIN000016198agasaki University Hospital100
已完成
不适用
Validation study on the effects on liver function and skin barrier function by intake of adlayHealthy AdultsJPRN-UMIN000041108Healthcare Systems Co., Ltd.70
招募中
不适用
The improvement effect of liver dysfanction and inhibitory effect of fibrosis marker by sitagliptin or repaglinide treatment for fatty liver(liver dysfunction) patients with type2 diabetes mellitus.Diabetes Mellitus Liver dysfunctionJPRN-UMIN000012513Osaka Medical College Hospital50
已完成
不适用
Evaluation for efficacy of liver function by ingestion of supplement containing plant derived extractiveHealthy subjectsJPRN-UMIN000027495TTC Co., Ltd.40
已完成
不适用
Modification of liver function and liver structure caused by parenteral nutritioK91.2Postsurgical malabsorption, not elsewhere classifiedDRKS00010993Charité - Universitätsmedizin Berlin Chirurgische Klinik Campus Charité Mitte l Campus Virchow-Klinikum90
